# AstraZeneca Pharmaceuticals LP, Mount Vernon, IN – FDA Inspections

Source: https://www.keypedia.com/companies/astrazeneca-pharmaceuticals-lp/80a406f0-7f62-4d81-841e-7f01c9950c06

> Inspection records and compliance data for AstraZeneca Pharmaceuticals LP in Mount Vernon, Indiana. 8 FDA inspections on record, 1 Form 483, last inspected September 19, 2023.

---

## Details

- Name: AstraZeneca Pharmaceuticals LP
- FEI Number: 1825662
- Address Line 1: 4601 Highway 62 E
- City: Mount Vernon
- State: Indiana
- Zip Code: 47620
- Country Name: United States
- Address: 4601 Highway 62 E, Mount Vernon, Indiana 47620, United States
- Country: United States

## Related Documents

- [483 - AstraZeneca Pharmaceuticals LP - 2023-09-19](https://www.keypedia.com/records/483/astrazeneca-pharmaceuticals-lp/588ae947-ca3a-4174-83f6-d54fc5ae8752) — source: FDA, date: September 19, 2023
- [FDA Inspection 1218331 - AstraZeneca Pharmaceuticals LP - 2023-09-19](https://www.keypedia.com/records/fda_inspections/astrazeneca-pharmaceuticals-lp/f66f66c2-0f6a-4aa1-972a-c17574142886) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 19, 2023
- FDA Inspection 965123 - AstraZeneca Pharmaceuticals LP - 2016-01-28 — classification: No Action Indicated (NAI), source: FDA, date: January 28, 2016
- FDA Inspection 853863 - AstraZeneca Pharmaceuticals LP - 2013-10-25 — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 25, 2013
- FDA Inspection 798609 - AstraZeneca Pharmaceuticals LP - 2012-09-13 — classification: No Action Indicated (NAI), source: FDA, date: September 13, 2012
- [FDA Inspection 751470 - AstraZeneca Pharmaceuticals LP - 2011-10-28](https://www.keypedia.com/records/fda_inspections/astrazeneca-pharmaceuticals-lp/5d401b01-20f7-49dd-b629-fc4aeae2f2cf) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 28, 2011
- FDA Inspection 741276 - AstraZeneca Pharmaceuticals LP - 2011-08-12 — classification: No Action Indicated (NAI), source: FDA, date: August 12, 2011
- FDA Inspection 664877 - AstraZeneca Pharmaceuticals LP - 2010-02-03 — classification: No Action Indicated (NAI), source: FDA, date: February 3, 2010
- FDA Inspection 566232 - AstraZeneca Pharmaceuticals LP - 2009-01-29 — classification: No Action Indicated (NAI), source: FDA, date: January 29, 2009

## Related Companies

- [Thymoorgan Pharmazie Gmbh](https://www.keypedia.com/companies/thymoorgan-pharmazie-gmbh/b58b84eb-57d4-4730-8fbb-58632f71023d)
- [Alphapharm Pty, Ltd.](https://www.keypedia.com/companies/alphapharm-pty-ltd/9007b3c5-9b83-4783-b65d-52eb0246708e)
- [Watson Pharma Private Limited](https://www.keypedia.com/companies/watson-pharma-private-limited/846d9c2f-be10-415a-b681-5436e078ebfd)
- [Bora Pharmaceuticals Laboratories, Inc](https://www.keypedia.com/companies/bora-pharmaceuticals-laboratories-inc/9bb86ed9-7d7d-4886-a145-b9497462c295)
- [Takeda GmbH, Plant Oranienburg](https://www.keypedia.com/companies/takeda-gmbh-plant-oranienburg/c72ad117-1d9b-474a-8d1a-c4d0e81e9ba8)
- [Glenmark Pharmaceuticals Limited](https://www.keypedia.com/companies/glenmark-pharmaceuticals-limited/dacc6330-129c-4ce4-8c41-f71525daebe5)
- [Lantheus Medical Imaging, Inc.](https://www.keypedia.com/companies/lantheus-medical-imaging-inc/6e9954f9-4df0-41b8-bad7-e8117a91ef76)
- [Cadila Pharmaceuticals Limited](https://www.keypedia.com/companies/cadila-pharmaceuticals-limited/ea4ece29-89c9-42f3-9afa-58348dc605b9)
- [Merck Serono S.p.A.](https://www.keypedia.com/companies/merck-serono-spa/052a4b09-0189-4f5c-bdcc-33182a7d3488)
- [IBSA Institut Biochimique SA](https://www.keypedia.com/companies/ibsa-institut-biochimique-sa/b4d0cf36-d7bc-4ea3-851a-9b0efe59255e)

## Related Officers

- [Joseph A. Piechocki](https://www.keypedia.com/people/joseph-a-piechocki/1977a57b-4976-4b01-b8da-66a84b26e803)